IBA completes sale of drug discovery arm

IBA completes sale of drug discovery arm

BRUSSELS, Nov 18 (Reuters) – Belgian IBA said on Monday it had completed the sale of its drug discovery arm Cisbio Bioassays business to private equity group Argos Soditic in a deal valuing the business at 25 million euros ($33.7 million). IBA said in a...